-
1
-
-
18344390418
-
ERBB receptors and cancer: the complexity of targeted inhibitors
-
Hynes, N. E. and Lane, H. A. 2005. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat. Rev. Cancer 5:341.
-
(2005)
Nat. Rev. Cancer
, vol.5
, pp. 341
-
-
Hynes, N.E.1
Lane, H.A.2
-
3
-
-
33745057881
-
HER2 mutation and response to trastuzumab therapy in non-small-cell lung cancer
-
Cappuzzo, F., Bemis, L. and Varella-Garcia, M. 2006. HER2 mutation and response to trastuzumab therapy in non-small-cell lung cancer. N. Engl. J. Med. 354:2619.
-
(2006)
N. Engl. J. Med.
, vol.354
, pp. 2619
-
-
Cappuzzo, F.1
Bemis, L.2
Varella-Garcia, M.3
-
4
-
-
33745727112
-
HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors
-
Wang, S. E., Narasanna, A., Perez-Torres, M. et al. 2006. HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors. Cancer Cell 10:25.
-
(2006)
Cancer Cell
, vol.10
, pp. 25
-
-
Wang, S.E.1
Narasanna, A.2
Perez-Torres, M.3
-
5
-
-
13844306484
-
Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapy
-
Friedman, L. M., Rinon, A., Schechter, B. et al. 2005. Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapy. Proc. Natl Acad. Sci. USA 102:1915.
-
(2005)
Proc. Natl Acad. Sci. USA
, vol.102
, pp. 1915
-
-
Friedman, L.M.1
Rinon, A.2
Schechter, B.3
-
6
-
-
0033608993
-
The ErbB-2/ HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors
-
Klapper, L. N., Glathe, S., Vaisman, N. et al. 1999. The ErbB-2/ HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors. Proc. Natl Acad. Sci. USA 96:4995.
-
(1999)
Proc. Natl Acad. Sci. USA
, vol.96
, pp. 4995
-
-
Klapper, L.N.1
Glathe, S.2
Vaisman, N.3
-
7
-
-
3543024857
-
Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen
-
Drebin, J. A., Link, V. C., Weinberg, R. A. and Greene, M. I. 1986. Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen. Proc. Natl Acad. Sci. USA 83:9129.
-
(1986)
Proc. Natl Acad. Sci. USA
, vol.83
, pp. 9129
-
-
Drebin, J.A.1
Link, V.C.2
Weinberg, R.A.3
Greene, M.I.4
-
8
-
-
0026610881
-
Humanization of an anti-p185HER2 antibody for human cancer therapy
-
Carter, P., Presta, L., Gorman, C. M. et al. 1992. Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc. Natl Acad. Sci. USA 89:4285.
-
(1992)
Proc. Natl Acad. Sci. USA
, vol.89
, pp. 4285
-
-
Carter, P.1
Presta, L.2
Gorman, C.M.3
-
9
-
-
34248641115
-
Cancer therapeutic antibodies come of age: targeting minimal residual disease
-
Ben-Kasus, T., Schechter, B., Sela, M. and Yarden, Y. 2007. Cancer therapeutic antibodies come of age: targeting minimal residual disease. Mol. Oncol. 1:42.
-
(2007)
Mol. Oncol.
, vol.1
, pp. 42
-
-
Ben-Kasus, T.1
Schechter, B.2
Sela, M.3
Yarden, Y.4
-
10
-
-
2942592008
-
Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib
-
Burris, H. A., 3rd 2004. Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib. Oncologist 9 (Suppl. 3):10.
-
(2004)
Oncologist
, vol.9
, Issue.SUPPL. 3
, pp. 10
-
-
Burris H.A., 3rd.1
-
11
-
-
0034076307
-
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
-
Clynes, R. A., Towers, T. L., Presta, L. G. and Ravetch, J. V. 2000. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets. Nat. Med. 6:443.
-
(2000)
Nat. Med.
, vol.6
, pp. 443
-
-
Clynes, R.A.1
Towers, T.L.2
Presta, L.G.3
Ravetch, J.V.4
-
12
-
-
65349101151
-
Ligand-independent HER2/HER3/PI3K complex is disrupted by trastuzu-mab and is effectively inhibited by the PI3K inhibitor GDC-0941
-
Junttila, T. T., Akita, R. W., Parsons, K. et al. 2009. Ligand-independent HER2/HER3/PI3K complex is disrupted by trastuzu-mab and is effectively inhibited by the PI3K inhibitor GDC-0941. Cancer Cell 15:429.
-
(2009)
Cancer Cell
, vol.15
, pp. 429
-
-
Junttila, T.T.1
Akita, R.W.2
Parsons, K.3
-
13
-
-
62549147841
-
Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: relevance of receptor endocytosis
-
Ben-Kasus, T., Schechter, B., Lavi, S., Yarden, Y. and Sela, M. 2009. Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: relevance of receptor endocytosis. Proc. Natl Acad. Sci. USA 106:3294.
-
(2009)
Proc. Natl Acad. Sci. USA
, vol.106
, pp. 3294
-
-
Ben-Kasus, T.1
Schechter, B.2
Lavi, S.3
Yarden, Y.4
Sela, M.5
-
14
-
-
77949903478
-
Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy
-
2010
-
Baselga, J., Gelmon, K. A., Verma, S. et al. 2009. Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy. J. Clin. Oncol. 28:1138. 2010.
-
(2009)
J. Clin. Oncol.
, vol.28
, pp. 1138
-
-
Baselga, J.1
Gelmon, K.A.2
Verma, S.3
-
15
-
-
42949157368
-
Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer
-
Musolino, A., Naldi, N., Bortesi, B. et al. 2008. Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer. J. Clin. Oncol. 26:1789.
-
(2008)
J. Clin. Oncol.
, vol.26
, pp. 1789
-
-
Musolino, A.1
Naldi, N.2
Bortesi, B.3
-
16
-
-
73649149433
-
Strongly enhanced antitumor activity of trastuzumab and pertuzumab combination treatment on HER2-positive human xenograft tumor models
-
Scheuer, W., Friess, T., Burtscher, H., Bossenmaier, B., Endl, J. and Hasmann, M. 2009. Strongly enhanced antitumor activity of trastuzumab and pertuzumab combination treatment on HER2-positive human xenograft tumor models. Cancer Res. 69:9330.
-
(2009)
Cancer Res
, vol.69
, pp. 9330
-
-
Scheuer, W.1
Friess, T.2
Burtscher, H.3
Bossenmaier, B.4
Endl, J.5
Hasmann, M.6
-
17
-
-
0030959114
-
A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors
-
Klapper, L. N., Vaisman, N., Hurwitz, E., Pinkas-Kramarski, R., Yarden, Y. and Sela, M. 1997. A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors. Oncogene 14:2099.
-
(1997)
Oncogene
, vol.14
, pp. 2099
-
-
Klapper, L.N.1
Vaisman, N.2
Hurwitz, E.3
Pinkas-Kramarski, R.4
Yarden, Y.5
Sela, M.6
-
18
-
-
33644600485
-
Humanization of a recombinant monoclonal antibody to produce a therapeutic HER dimerization inhibitor, pertuzumab
-
Adams, C. W., Allison, D. E., Flagella, K. et al. 2006. Humanization of a recombinant monoclonal antibody to produce a therapeutic HER dimerization inhibitor, pertuzumab. Cancer Immunol. Immun-other. 55:717.
-
(2006)
Cancer Immunol. Immun-other.
, vol.55
, pp. 717
-
-
Adams, C.W.1
Allison, D.E.2
Flagella, K.3
-
19
-
-
1842605531
-
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex
-
Franklin, M. C., Carey, K. D., Vajdos, F. F. et al. 2004. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex. Cancer Cell 5:317.
-
(2004)
Cancer Cell
, vol.5
, pp. 317
-
-
Franklin, M.C.1
Carey, K.D.2
Vajdos, F.F.3
-
20
-
-
0026091927
-
Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth
-
Stancovski, I., Hurwitz, E., Leitner, O., Ullrich, A., Yarden, Y. and Sela, M. 1991. Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth. Proc. Natl Acad. Sci. USA 88:8691.
-
(1991)
Proc. Natl Acad. Sci. USA
, vol.88
, pp. 8691
-
-
Stancovski, I.1
Hurwitz, E.2
Leitner, O.3
Ullrich, A.4
Yarden, Y.5
Sela, M.6
-
21
-
-
0032850677
-
Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease
-
Cobleigh, M. A., Vogel, C. L., Tripathy, D. et al. 1999. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J. Clin. Oncol. 17:2639.
-
(1999)
J. Clin. Oncol.
, vol.17
, pp. 2639
-
-
Cobleigh, M.A.1
Vogel, C.L.2
Tripathy, D.3
-
22
-
-
34247891741
-
More than one reason to rethink the use of peptides in vaccine design
-
Purcell, A. W., McCluskey, J. and Rossjohn, J. 2007. More than one reason to rethink the use of peptides in vaccine design. Nat. Rev. Drug Discov. 6:404.
-
(2007)
Nat. Rev. Drug Discov.
, vol.6
, pp. 404
-
-
Purcell, A.W.1
McCluskey, J.2
Rossjohn, J.3
-
23
-
-
0034054912
-
Peptide mimotopes as candidate vaccines
-
Partidos, C. D. 2000. Peptide mimotopes as candidate vaccines. Curr. Opin. Mol. Ther. 2:74.
-
(2000)
Curr. Opin. Mol. Ther.
, vol.2
, pp. 74
-
-
Partidos, C.D.1
-
24
-
-
54749157038
-
DNA vaccination controls Her-2+ tumors that are refractory to targeted therapies
-
Whittington, P. J., Piechocki, M. P., Heng, H. H. et al. 2008. DNA vaccination controls Her-2+ tumors that are refractory to targeted therapies. Cancer Res 68:7502.
-
(2008)
Cancer Res
, vol.68
, pp. 7502
-
-
Whittington, P.J.1
Piechocki, M.P.2
Heng, H.H.3
-
25
-
-
0027997807
-
Antigenic and immunogenic mimicry of the HER2/neu oncoprotein by phage-displayed peptides
-
Orlandi, R., Menard, S., Colnaghi, M. I., Boyer, C. M. and Felici, F. 1994. Antigenic and immunogenic mimicry of the HER2/neu oncoprotein by phage-displayed peptides. Eur. J. Immunol. 24:2868.
-
(1994)
Eur. J. Immunol.
, vol.24
, pp. 2868
-
-
Orlandi, R.1
Menard, S.2
Colnaghi, M.I.3
Boyer, C.M.4
Felici, F.5
-
26
-
-
0034454290
-
Specific inhibition of the reaction between a tumor-inhibitory antibody and the ErbB-2 receptor by a mimotope derived from a phage display library
-
Vaisman, N., Nissim, A., Klapper, L. N., Tirosh, B., Yarden, Y. and Sela, M. 2000. Specific inhibition of the reaction between a tumor-inhibitory antibody and the ErbB-2 receptor by a mimotope derived from a phage display library. Immunol. Lett. 75:61.
-
(2000)
Immunol. Lett.
, vol.75
, pp. 61
-
-
Vaisman, N.1
Nissim, A.2
Klapper, L.N.3
Tirosh, B.4
Yarden, Y.5
Sela, M.6
-
27
-
-
0035871618
-
Identification of epitope regions recognized by tumor inhibitory and stimulatory anti-ErbB-2 monoclonal antibodies: implications for vaccine design
-
Yip, Y. L., Smith, G., Koch, J., Dubel, S. and Ward, R. L. 2001. Identification of epitope regions recognized by tumor inhibitory and stimulatory anti-ErbB-2 monoclonal antibodies: implications for vaccine design. J. Immunol. 166:5271.
-
(2001)
J. Immunol.
, vol.166
, pp. 5271
-
-
Yip, Y.L.1
Smith, G.2
Koch, J.3
Dubel, S.4
Ward, R.L.5
-
28
-
-
2942741136
-
Generation of peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu
-
Riemer, A. B., Klinger, M., Wagner, S. et al. 2004. Generation of peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu. J. Immunol. 173:394.
-
(2004)
J. Immunol.
, vol.173
, pp. 394
-
-
Riemer, A.B.1
Klinger, M.2
Wagner, S.3
-
29
-
-
34249820537
-
Novel engineered trastuzumab conformational epitopes demonstrate in vitro and in vivo antitumor properties against HER-2/neu
-
Garrett, J. T., Rawale, S., Allen, S. D. et al. 2007. Novel engineered trastuzumab conformational epitopes demonstrate in vitro and in vivo antitumor properties against HER-2/neu. J. Immunol. 178:7120.
-
(2007)
J. Immunol.
, vol.178
, pp. 7120
-
-
Garrett, J.T.1
Rawale, S.2
Allen, S.D.3
-
30
-
-
77955555499
-
Identification and characterization of Ch806 mimotopes
-
Yang, L., Jiang, H., Shi, B. et al. 2010. Identification and characterization of Ch806 mimotopes. Cancer Immunol. Immun-other. 59:1481.
-
(2010)
Cancer Immunol. Immun-other.
, vol.59
, pp. 1481
-
-
Yang, L.1
Jiang, H.2
Shi, B.3
-
31
-
-
27944464948
-
Vaccination with cetuximab mimotopes and biological properties of induced anti-epidermal growth factor receptor antibodies
-
Riemer, A. B., Kurz, H., Klinger, M., Scheiner, O., Zielinski, C. C. and Jensen-Jarolim, E. 2005. Vaccination with cetuximab mimotopes and biological properties of induced anti-epidermal growth factor receptor antibodies. J. Natl Cancer Inst. 97:1663.
-
(2005)
J. Natl Cancer Inst.
, vol.97
, pp. 1663
-
-
Riemer, A.B.1
Kurz, H.2
Klinger, M.3
Scheiner, O.4
Zielinski, C.C.5
Jensen-Jarolim, E.6
-
32
-
-
77955655880
-
Peptide mimotopes recognized by antibodies cetuximab and matuzumab induce a functionally equivalent anti-EGFR immune response
-
Hartmann, C., Muller, N., Blaukat, A., Koch, J., Benhar, I. and Wels, W. S. 2010. Peptide mimotopes recognized by antibodies cetuximab and matuzumab induce a functionally equivalent anti-EGFR immune response. Oncogene 29:4517.
-
(2010)
Oncogene
, vol.29
, pp. 4517
-
-
Hartmann, C.1
Muller, N.2
Blaukat, A.3
Koch, J.4
Benhar, I.5
Wels, W.S.6
-
33
-
-
0035874389
-
The rational design of a 'type 88' genetically stable peptide display vector in the filamentous bacteriophage fd
-
Enshell-Seijffers, D., Smelyanski, L. and Gershoni, J. M. 2001. The rational design of a 'type 88' genetically stable peptide display vector in the filamentous bacteriophage fd. Nucleic Acids Res. 29:E50.
-
(2001)
Nucleic Acids Res
, vol.29
-
-
Enshell-Seijffers, D.1
Smelyanski, L.2
Gershoni, J.M.3
-
34
-
-
43549089490
-
Phage display selection and analysis of Ab-binding epitopes
-
Chapter 9:Unit 9.8.1-9.8.27
-
Enshell-Seijffers, D. and Gershoni, J. M. 2002. Phage display selection and analysis of Ab-binding epitopes. Curr. Protoc. Immunol. Chapter 9:Unit 9.8.1-9.8.27.
-
(2002)
Curr. Protoc. Immunol.
-
-
Enshell-Seijffers, D.1
Gershoni, J.M.2
-
35
-
-
20244367576
-
Bivalence of EGF-like ligands drives the ErbB signaling network
-
Tzahar, E., Pinkas-Kramarski, R., Moyer, J. D. et al. 1997. Bivalence of EGF-like ligands drives the ErbB signaling network. EMBO J. 16:4938.
-
(1997)
EMBO J
, vol.16
, pp. 4938
-
-
Tzahar, E.1
Pinkas-Kramarski, R.2
Moyer, J.D.3
-
36
-
-
13344284648
-
An immunological approach reveals biological differences between the two NDF/ heregulin receptors, ErbB-3 and ErbB-4
-
Chen, X., Levkowitz, G., Tzahar, E. et al. 1996. An immunological approach reveals biological differences between the two NDF/ heregulin receptors, ErbB-3 and ErbB-4. J. Biol. Chem. 271:7620.
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 7620
-
-
Chen, X.1
Levkowitz, G.2
Tzahar, E.3
-
37
-
-
0028819660
-
Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model
-
Goldstein, N. I., Prewett, M., Zuklys, K., Rockwell, P. and Mendelsohn, J. 1995. Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model. Clin. Cancer Res. 1:1311.
-
(1995)
Clin. Cancer Res.
, vol.1
, pp. 1311
-
-
Goldstein, N.I.1
Prewett, M.2
Zuklys, K.3
Rockwell, P.4
Mendelsohn, J.5
-
38
-
-
44449099824
-
Synthesis and application of peptide dendrimers as protein mimetics
-
Chapter 9:Unit 9.6
-
Tam, J. P. and Spetzler, J. C. 2001. Synthesis and application of peptide dendrimers as protein mimetics. Curr. Protoc. Immunol. Chapter 9:Unit 9.6.
-
(2001)
Curr. Protoc. Immunol.
-
-
Tam, J.P.1
Spetzler, J.C.2
-
39
-
-
0142195767
-
The mapping and reconstitution of a conformational discontinuous B-cell epitope of HIV-1
-
Enshell-Seijffers, D., Denisov, D., Groisman, B. et al. 2003. The mapping and reconstitution of a conformational discontinuous B-cell epitope of HIV-1. J. Mol. Biol. 334:87.
-
(2003)
J. Mol. Biol.
, vol.334
, pp. 87
-
-
Enshell-Seijffers, D.1
Denisov, D.2
Groisman, B.3
-
40
-
-
34249886331
-
Stepwise prediction of conformational discontinuous B-cell epitopes using the Mapitope algorithm
-
Bublil, E. M., Freund, N. T., Mayrose, I. et al. 2007. Stepwise prediction of conformational discontinuous B-cell epitopes using the Mapitope algorithm. Proteins 68:294.
-
(2007)
Proteins
, vol.68
, pp. 294
-
-
Bublil, E.M.1
Freund, N.T.2
Mayrose, I.3
-
41
-
-
0037434791
-
Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab
-
Cho, H. S., Mason, K., Ramyar, K. X. et al. 2003. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 421:756.
-
(2003)
Nature
, vol.421
, pp. 756
-
-
Cho, H.S.1
Mason, K.2
Ramyar, K.X.3
-
42
-
-
69849095169
-
Automated detection of conformational epitopes using phage display peptide sequences
-
Negi, S. S. and Braun, W. 2009. Automated detection of conformational epitopes using phage display peptide sequences. Bioinform. Biol. Insights 3:71.
-
(2009)
Bioinform. Biol. Insights
, vol.3
, pp. 71
-
-
Negi, S.S.1
Braun, W.2
-
44
-
-
65449188232
-
Jalview Version 2-a multiple sequence alignment editor and analysis workbench
-
Waterhouse, A. M., Procter, J. B., Martin, D. M., Clamp, M. and Barton, G. J. 2009. Jalview Version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics 25:1189.
-
(2009)
Bioinformatics
, vol.25
, pp. 1189
-
-
Waterhouse, A.M.1
Procter, J.B.2
Martin, D.M.3
Clamp, M.4
Barton, G.J.5
-
45
-
-
0020475449
-
A simple method for displaying the hydropathic character of a protein
-
Kyte, J. and Doolittle, R. F. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105.
-
(1982)
J. Mol. Biol.
, vol.157
, pp. 105
-
-
Kyte, J.1
Doolittle, R.F.2
-
46
-
-
0028917153
-
Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage
-
Meola, A., Delmastro, P., Monaci, P. et al. 1995. Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage. J. Immunol. 154:3162.
-
(1995)
J. Immunol.
, vol.154
, pp. 3162
-
-
Meola, A.1
Delmastro, P.2
Monaci, P.3
-
47
-
-
0030796474
-
Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration
-
Delmastro, P., Meola, A., Monaci, P., Cortese, R. and Galfre, G. 1997. Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration. Vaccine 15:1276.
-
(1997)
Vaccine
, vol.15
, pp. 1276
-
-
Delmastro, P.1
Meola, A.2
Monaci, P.3
Cortese, R.4
Galfre, G.5
-
48
-
-
0031759241
-
Peptide mimotopes displayed by phage inhibit antibody binding to bet v. 1, the major birch pollen allergen, and induce specific IgG response in mice
-
Jensen-jarolim, E., Leitner, A., Kalchhauser, H. et al. 1998. Peptide mimotopes displayed by phage inhibit antibody binding to bet v. 1, the major birch pollen allergen, and induce specific IgG response in mice. FASEB J. 12:1635.
-
(1998)
FASEB J
, vol.12
, pp. 1635
-
-
Jensen-jarolim, E.1
Leitner, A.2
Kalchhauser, H.3
-
49
-
-
0033729843
-
Allergen mimotopes for 3-dimensional epitope search and induction of antibodies inhibiting human IgE
-
Ganglberger, E., Grunberger, K., Sponer, B. et al. 2000. Allergen mimotopes for 3-dimensional epitope search and induction of antibodies inhibiting human IgE. FASEB J. 14:2177.
-
(2000)
FASEB J
, vol.14
, pp. 2177
-
-
Ganglberger, E.1
Grunberger, K.2
Sponer, B.3
-
50
-
-
77955657213
-
Antigen-specific therapy of EAE via intranasal delivery of filamentous phage displaying a myelin immunodominant epitope
-
Rakover, I. S., Zabavnik, N., Kopel, R., Paz-Rozner, M. and Solomon, B. 2010. Antigen-specific therapy of EAE via intranasal delivery of filamentous phage displaying a myelin immunodominant epitope. J. Neuroimmunol. 225:68.
-
(2010)
J. Neuroimmunol.
, vol.225
, pp. 68
-
-
Rakover, I.S.1
Zabavnik, N.2
Kopel, R.3
Paz-Rozner, M.4
Solomon, B.5
-
51
-
-
13544277841
-
EFRH-phage immunization of Alzheimer's disease animal model improves behavioral performance in Morris water maze trials
-
Lavie, V., Becker, M., Cohen-Kupiec, R. et al. 2004. EFRH-phage immunization of Alzheimer's disease animal model improves behavioral performance in Morris water maze trials. J. Mol. Neurosci. 24:105.
-
(2004)
J. Mol. Neurosci.
, vol.24
, pp. 105
-
-
Lavie, V.1
Becker, M.2
Cohen-Kupiec, R.3
-
52
-
-
33845665424
-
Comparison of phage pVIII and KLH as vector in inducing the production of cytokines in C57BL/6J mice
-
Su, Q. P., Wen, D. Z., Yang, Q., Zhang, Y. H., Liu, C. and Wang, L. 2007. Comparison of phage pVIII and KLH as vector in inducing the production of cytokines in C57BL/6J mice. Vaccine 25:970.
-
(2007)
Vaccine
, vol.25
, pp. 970
-
-
Su, Q.P.1
Wen, D.Z.2
Yang, Q.3
Zhang, Y.H.4
Liu, C.5
Wang, L.6
-
53
-
-
0001331728
-
Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system
-
Tam, J. P. 1988. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl Acad. Sci. USA 85:5409.
-
(1988)
Proc. Natl Acad. Sci. USA
, vol.85
, pp. 5409
-
-
Tam, J.P.1
-
54
-
-
0024310231
-
Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B- cell epitopes
-
Tam, J. P. and Lu, Y. A. 1989. Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B- cell epitopes. Proc. Natl Acad. Sci. USA 86:9084.
-
(1989)
Proc. Natl Acad. Sci. USA
, vol.86
, pp. 9084
-
-
Tam, J.P.1
Lu, Y.A.2
-
55
-
-
0028960723
-
Unprotected peptides as building blocks for the synthesis of peptide dendrimers with oxime, dydrazone and thiazolidine linkages
-
Shao, J. and Tam, J. P. 1995. Unprotected peptides as building blocks for the synthesis of peptide dendrimers with oxime, dydrazone and thiazolidine linkages. J. Am. Chem. Soc. 117:3893.
-
(1995)
J. Am. Chem. Soc.
, vol.117
, pp. 3893
-
-
Shao, J.1
Tam, J.P.2
|